Webinars

Webinar: “Orphan Medicinal Products Old myths and new realities” - 23rd June 2021

Robin Lachmann - Presentation

37 mins

Sandra Sirrs - Presentation

30 mins

Q&A Session

24 mins

Full Webinar

94 mins

Webinar Summary & Objectives:

  • Describe the increasing impact of OMPs on healthcare costs
  • Describe societal challenges that may complicate efforts to control drug prices for OMPs
  • Describe ways in which development programs and market access for OMPs differ from those for common disease drugs

WEBINAR: “Childhood Hypoglycaemia why worry? ….” - 12th May 2021

SPEAKERS:

+ Dr Indi Banerjee, Consultant in Paediatric Endocrinology at Manchester University NHS Foundation Trust
+ Prof. John Walter, Honorary Clinical Professor, Inherited Metabolic Medicine Developmental Biology and Medicine, School of Medical Sciences,  University of Manchester, UK
+ Dr Elisabeth Jameson, Former Consultant in Paediatric Inborn Errors of Metabolism Manchester Centre for Genomic Medicine Manchester Universities NHS Foundation Trust

WEBINAR OBJECTIVES:

  • What is the emergency management of hypoglycaemia? What are the important initial investigations?
  • What are the causes of hyperinsulinism in childhood? How do they present and how are they diagnosed and managed?
  • Which inherited metabolic disorders present with hypoglycaemia in childhood? How do they present and how are they diagnosed and managed?

What's new in Neurometabolic Disease: Webinar - 17th February 2021

SPEAKERS:

+ Angeles García-Cazorla, Sant Joan de Déu Hospital, Barcelona
+ Fanny Mochel Pitié-Salpêtrière Hospital, Paris

WEBINAR OBJECTIVES:

When to consider a metabolic disease in patients with neurological signs?
How to diagnose such diseases?
What treatment and family care shall be initiated without delay?

SUMMARY:

The webinar will be split into a paediatric and adult perspective with clinical cases illustrating new neurometabolic diseases described in the last 3-4 years, with biomarkers, and the growing place of these disorders in adult neurology.

Each clinical case will introduce important aspects to be discussed such as; differential diagnosis, the hard pathway through discovery and validation of new disorders, new available biomarkers and the opportunities for new treatments.